Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need

References

• Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Mantzoros CS. Leptin in health and disease: facts and expectations at its twentieth anniversary. Metabolism. 2015;64(1):5–12.
   PubMed Web of Science ®Google Scholar
• Leshan RL, Björnholm M, Münzberg H, et al. Leptin receptor signaling and action in the Central nervous system. Obesity. 2006;14(Suppl 5):208s–212s.
   PubMed Web of Science ®Google Scholar
• Cinti S, Frederich RC, Zingaretti MC, et al. Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. Endocrinology. 1997;138(2):797–804.
   PubMed Web of Science ®Google Scholar
• Mantzoros CS, Moschos S, Avramopoulos I, et al. Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. J Clin Endocrinol Metab. 1997;82(10):3408–3413.
   PubMed Web of Science ®Google Scholar
• Wolfe BE, Jimerson DC, Orlova C, et al. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol. 2004;61(3):332–338.
   PubMed Web of Science ®Google Scholar
• Moon HS, Dalamaga M, Kim SY, et al. Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev. 2013;34(3):377–412.
   PubMed Web of Science ®Google Scholar
• Shetty GK, Matarese G, Magkos F, et al. Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet. Eur J Endocrinol. 2011;165(2):249–254.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Zavos C, et al. The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature. J Clin Gastroenterol. 2011;45(1):50–54.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Aronis KN, Kountouras J, et al. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Diabetologia. 2016;59(1):30–43.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Perakakis N, Mantzoros CS. Fatty liver in lipodystrophy: a review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement. Metabolism. 2019;96:66–82.
   PubMed Web of Science ®Google Scholar
• Vatier C, Vantyghem MC, Storey C, et al. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases. Curr Med Res Opin. 2019;35(3):543–552.
   PubMed Web of Science ®Google Scholar
• Haque WA, Shimomura I, Matsuzawa Y, et al. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002;87(5):2395–2395.
   PubMed Web of Science ®Google Scholar
• Brown RJ, Oral EA, Cochran E, et al. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. Endocrine. 2018;60(3):479–489.
   PubMed Web of Science ®Google Scholar
• Chevalier B, Lemaitre M, Leguier L, et al. Metreleptin treatment of non-HIV lipodystrophy syndromes. Presse Med. 2021;50(3):104070.
   PubMed Web of Science ®Google Scholar
• Adamski K, Cook K, Gupta D, et al. Effects of metreleptin in patients with lipodystrophy with and without baseline concomitant medication use. Curr Med Res Opin. 2021;37(11):1881–1889.
   PubMed Web of Science ®Google Scholar
• Cook K, Adamski K, Gomes A, et al. Effects of metreleptin on patient outcomes and quality of life in generalized and partial lipodystrophy. J Endocr Soc. 2021;5(4):bvab019.
   PubMed Web of Science ®Google Scholar
• Cook K, Ali O, Akinci B, et al. Effect of leptin therapy on survival in generalized and partial lipodystrophy: a matched cohort analysis. J Clin Endocrinol Metab. 2021;106(8):e2953–e2967.
   PubMed Web of Science ®Google Scholar
• Akinci B, Subauste A, Ajluni N, et al. Metreleptin therapy for nonalcoholic steatohepatitis: open-label therapy interventions in two different clinical settings. Med. 2021;2(7):814–835.
   PubMed Web of Science ®Google Scholar
• Javor ED, Ghany MG, Cochran EK, et al. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. Hepatology. 2005;41(4):753–760.
   PubMed Web of Science ®Google Scholar
• Safar Zadeh E, Lungu AO, Cochran EK, et al. The liver diseases of lipodystrophy: the long-term effect of leptin treatment. J Hepatol. 2013;59(1):131–137.
   PubMed Web of Science ®Google Scholar
• Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346(8):570–578.
   PubMed Web of Science ®Google Scholar
• Perakakis N, Farr OM, Mantzoros CS. Leptin in leanness and obesity: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77(6):745–760.
   PubMed Web of Science ®Google Scholar
• Angelidi AM, Filippaios A, Mantzoros CS. Severe insulin resistance syndromes. J Clin Invest. 2021;131(4):e142245.
   PubMed Web of Science ®Google Scholar
• Shamsudeen I, Hegele RA. Advances in the care of lipodystrophies. Curr Opin Endocrinol Diabetes Obes. 2022;29(2):152–160.
   PubMedGoogle Scholar
• Magkos F, Brennan A, Sweeney L, et al. Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study. Metabolism. 2011;60(7):1045–1049.
   PubMed Web of Science ®Google Scholar
• Foo JP, Polyzos SA, Anastasilakis AD, et al. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. J Clin Endocrinol Metab. 2014;99(11):E2252–E2258.
   PubMed Web of Science ®Google Scholar
• Chou SH, Chamberland JP, Liu X, et al. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci USA. 2011;108(16):6585–6590.
   PubMed Web of Science ®Google Scholar